Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Asthma%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22
/vufind/Search/Results?lookfor=%22Asthma%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22
Search /vufind/Search2/Results?lookfor=%22Asthma%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22
PubPharm (2.008)
1
Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma : A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled 28-week Phase 3 Efficacy and Safety Study of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma (SUNRISE)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared to CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid : A 12 Week, Randomized, Double-blind, Multicenter, Active Controlled, 2-Arm Parallel Group Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose (Fixed Combination of Extrafine Beclomethasone Dipropionate Plus Formoterol Fumarate) Compared to CHF 718 pMDI 800µg Total Daily Dose (Extrafine Beclomethasone Dipropionate) in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma : A Multicentre, Randomised, Double-Blind, Parallel-Group Placebo-Controlled, Phase 3, Efficacy and Safety Study of Tezepelumab in 5 to < 12 Year Old Children With Severe Uncontrolled Asthma (HORIZON)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations : A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway Obstruction : ALTA - ALbuterol/Budesonide Treatment in Acute Airway Obstruction. A Randomized, Double-blind, 2-period, Cross-over Study Evaluating Efficacy and Safety of Repeated Doses of PT027 Compared to PT007 in Patients With Asthma and Acute Airway Obstruction Induced by Repeated Mannitol Challenges
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma : A Multicentre, Single-arm, Phase 3b Efficacy and Safety Study of Tezepelumab 210 mg Administered Subcutaneously to Reduce Oral Corticosteroid Use in Adult Participants With Severe Asthma on High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist and Long-term Oral Corticosteroid Therapy (WAYFINDER)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma : A Randomized, Double-blind, Multicenter, Parallel Group, Phase IIIb 52 Week Study Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma (ACADIA)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS) : A Randomized, Double-Blind, Parallel Group, Multicenter 12 Week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS) : A Randomized, Double-Blind, Parallel Group, Multicenter 24 Week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler and Open-Label Symbicort® Turbuhaler® in Participants With Inadequately Controlled Asthma (VATHOS).
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Evaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma : Evaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[201]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 3
Medienart
2.008
Aufsätze
2.008
E-Artikel
2.008
E-Ressourcen
Zeitschriftentitel
1.494
WHO International Clinical Trials Registry Plat...
514
ClinicalTrials.gov
Thema
2.008
610
Phase: Phase 3
2.004
Study Type: Interventional
1.078
Recruitment Status: Not yet recruiting
510
Recruitment Status: Completed
484
Asthma
326
Medical Condition: Asthma
174
Medical Condition: Asthma MedDRA version: 20.0L...
162
Recruitment Status: Authorised-recruitment may ...
96
Medical Condition: Asthma MedDRA version: 20.0 ...
91
Recruitment Status: Recruiting
58
Medical Condition: Asthma MedDRA version: 18.1L...
32
Medical Condition: Asthma;Therapeutic area: Dis...
30
Medical Condition: Severe asthma with an eosino...
26
Medical Condition: Asthma; Asthma;Respiratory -...
26
Recruitment Status: Terminated
24
Medical Condition: Health Condition 1: J454- Mo...
24
Medical Condition: Severe uncontrolled asthma w...
22
Medical Condition: Asthma MedDRA version: 19.0L...
22
Medical Condition: Health Condition 1: null- As...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
957
2020-
1.026
2010-2019
25
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.992
Englisch
8
Unbestimmt
6
Spanisch
2
Portugiesisch
Haven't found what you're looking for?
Wird geladen...